What role can data play in developing community-based approaches to opioid misuse prevention, treatment, and recovery? How can data help health, law enforcement, and criminal justice professionals—and community members—better understand the opioid crisis in their localities and develop targeted interventions? Please join AIR to explore these and other issues in ...
COVID-19 has profoundly disrupted K–12 schooling. A working paper from AIR’s National Center for Analysis of Longitudinal Data in Education Research (CALDER) suggests the prevalence of COVID in the community could be an important factor in deciding whether public schools reopen or remain open.
The Local Control Funding Formula (LCFF) represents a fundamental transformation of the way California allocates state funds to school districts and the ways the state expects districts to make decisions about (and report on) the use of these funds. This brief identifies some early lessons about how best to use ...
Dr. Elizabeth Salisbury-Afshar, a practicing physician, researcher, and director of the AIR Center for Addiction Research and Effective Solutions (AIR CARES), provides some advice for finding reliable sources of information, rooted in science and evidence, while avoiding a sense of panic.
Rural and urban communities alike have experienced an overdose crisis, but there are some known differences in access to treatment and general health care. AIR and IMPAQ experts analyzed data from a recent U.S. Department of Health and Human Services Office of the Inspector General study to further understand differences ...
This spotlight takes a look at the history of Title I, how the program has changed over time, and how it affects children, schools, families and education policy. Experts weigh in on the program's past and future in interviews, briefs, and blogs.
Melissa Hafner is a health policy researcher at AIR. Prior to joining AIR, she conducted health research at Mathematica Policy Research and the Massachusetts Medical Society. She also served as a senior program analyst in the Office of the Inspector General at the U.S. Department of Health and Human Services, ...
Biological drugs, or biologics, are innovative therapies for people with debilitating and life-threatening diseases; but these drugs are expensive. In this Q&A, AIR’s Thiyagu Rajakannan, senior researcher and lead for Drug Coverage and Payment Practice in the Health Division at AIR, explains how lower-cost versions of these drugs and promising ...
AIR is committed to increasing the effectiveness of education globally at all levels through the provision of safe, supportive, and equitable learning environments. Our rigorous, state-of-the-art research and evaluation work provides important evidence for education policymakers and practitioners to use when answering crucial questions about program implementation, challenges, and solutions. ...
Amanda Latimore, Ph.D., leads AIR’s Center for Addiction Research and Effective Solutions (AIR CARES). She also teaches social epidemiology as an adjunct assistant professor at the Johns Hopkins Bloomberg School of Public Health.